![Crispr-Cas9 illustration](https://technewslit.com/sciencebusiness/wp-content/uploads/2017/04/CrisprCas9_LBLgov-150x100.jpg)
The company developing a treatment for a rare inherited eye disease using the genome editing technique Crispr received authorization from the Food and Drug Administration to begin clinical trials. . . . → Read More: Trials OK’d for Inherited Eye Disease Therapy with Crispr